{"url_path":"/sec/gmrs/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1898718/0001104659-26-069410-index.html","accession_number":"0001104659-26-069410","cik":"0001898718","ticker":"GMRS","issuer_name":"GMR Solutions Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1898718/0001104659-26-069410-index.html","primary_entity_key":"0001898718","primary_entity_name":"GMR Solutions Inc."},"word_count":1194,"has_tables":true,"body_markdown":"GMR Solutions Inc._March 31, 2026\n\n0001898718--12-312026Q1falsehttp://fasb.org/us-gaap/2026#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2026#OtherAssetsNoncurrenthttp://www.globalmedicalresponse.com/20260331#InsuranceCollateralCurrenthttp://www.globalmedicalresponse.com/20260331#InsuranceCollateralCurrent362162551212http://fasb.org/us-gaap/2026#SecuredOvernightFinancingRateSofrMember0.333371034740001898718us-gaap:RetainedEarningsMember2026-03-310001898718us-gaap:AdditionalPaidInCapitalMember2026-03-310001898718us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001898718us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-03-310001898718us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2026-03-310001898718us-gaap:RetainedEarningsMember2025-12-310001898718us-gaap:AdditionalPaidInCapitalMember2025-12-310001898718us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001898718us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-12-310001898718us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-12-310001898718us-gaap:RetainedEarningsMember2025-03-310001898718us-gaap:AdditionalPaidInCapitalMember2025-03-310001898718us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001898718us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-03-310001898718us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-03-310001898718us-gaap:RetainedEarningsMember2024-12-310001898718us-gaap:AdditionalPaidInCapitalMember2024-12-310001898718us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001898718us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-12-310001898718us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-12-310001898718gmrs:AmendedEquityPlan2015Member2024-07-260001898718us-gaap:RestrictedStockMembergmrs:AmendedEquityPlan2015Member2026-01-012026-03-3100018987182026-04-012026-03-310001898718us-gaap:HealthCarePatientServiceMember2026-01-012026-03-310001898718gmrs:SelfPaymentMember2026-01-012026-03-310001898718gmrs:OtherThirdPartyPayorsMember2026-01-012026-03-310001898718gmrs:MedicareMember2026-01-012026-03-310001898718gmrs:MedicaidMember2026-01-012026-03-310001898718gmrs:ComplementaryRevenueMember2026-01-012026-03-310001898718gmrs:CommercialInsuranceAndManagedCareExcludingMedicareAndMedicaidManagedCareMember2026-01-012026-03-310001898718us-gaap:HealthCarePatientServiceMember2025-01-012025-03-310001898718gmrs:SelfPaymentMember2025-01-012025-03-310001898718gmrs:OtherThirdPartyPayorsMember2025-01-012025-03-310001898718gmrs:MedicareMember2025-01-012025-03-310001898718gmrs:MedicaidMember2025-01-012025-03-310001898718gmrs:ComplementaryRevenueMember2025-01-012025-03-310001898718gmrs:CommercialInsuranceAndManagedCareExcludingMedicareAndMedicaidManagedCareMember2025-01-012025-03-310001898718gmrs:FirstLienTermLoan2023Memberus-gaap:SubsequentEventMemberus-gaap:IPOMember2026-05-142026-05-140001898718us-gaap:RevolvingCreditFacilityMember2026-01-012026-03-310001898718us-gaap:RevolvingCreditFacilityMember2025-01-012025-12-310001898718srt:MaximumMember2024-05-012024-05-310001898718us-gaap:CommonClassAMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2026-05-142026-05-140001898718us-gaap:SubsequentEventMember2026-05-142026-05-140001898718us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001898718us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-01-012026-03-310001898718us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001898718us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-03-310001898718us-gaap:RetainedEarningsMember2026-01-012026-03-310001898718us-gaap:RetainedEarningsMember2025-01-012025-03-310001898718us-gaap:RevolvingCreditFacilityMember2026-03-310001898718us-gaap:LetterOfCreditMember2026-03-310001898718us-gaap:TradeNamesMember2026-03-310001898718gmrs:CertificatesOfNeedMember2026-03-310001898718us-gaap:TradeNamesMember2025-12-310001898718gmrs:CertificatesOfNeedMember2025-12-310001898718srt:MinimumMemberus-gaap:NoncompeteAgreementsMember2026-03-310001898718srt:MinimumMemberus-gaap:CustomerRelationshipsMember2026-03-310001898718srt:MaximumMemberus-gaap:NoncompeteAgreementsMember2026-03-310001898718srt:MaximumMemberus-gaap:CustomerRelationshipsMember2026-03-310001898718us-gaap:TradeNamesMember2026-03-310001898718us-gaap:NoncompeteAgreementsMember2026-03-310001898718us-gaap:CustomerRelationshipsMember2026-03-310001898718gmrs:MembershipListsMember2026-03-310001898718us-gaap:TradeNamesMember2025-12-310001898718us-gaap:NoncompeteAgreementsMember2025-12-310001898718us-gaap:CustomerRelationshipsMember2025-12-310001898718gmrs:MembershipListsMember2025-12-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember302026TwoMember2026-02-012026-02-280001898718gmrs:InterestRateSwapEffectiveDateOfNovember302026OneMember2025-12-012025-12-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember282025Member2025-03-012025-03-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember292024TwoMember2024-08-012024-08-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember292024OneMember2024-08-012024-08-310001898718srt:MaximumMembergmrs:InterestRateSwapEffectiveDateOfNovember292024Member2026-03-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember282025Member2026-03-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember292024Member2025-12-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember282025Member2025-12-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember302026TwoMember2026-02-280001898718gmrs:InterestRateSwapEffectiveDateOfNovember282025Member2025-03-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember292024TwoMember2024-08-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember292024OneMember2024-08-310001898718us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2026-03-310001898718us-gaap:InterestRateSwapMember2026-03-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember302026TwoMember2026-03-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember302026OneMember2026-03-310001898718us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2025-12-310001898718us-gaap:InterestRateSwapMember2025-12-310001898718gmrs:InterestRateSwapEffectiveDateOfNovember302026OneMember2025-12-310001898718gmrs:SeniorSecuredTermLoansMember2025-01-012025-12-310001898718us-gaap:SecuredDebtMember2026-03-310001898718gmrs:SeniorSecuredTermLoansMember2026-03-310001898718gmrs:SeniorSecuredNotesMember2026-03-310001898718gmrs:OtherLongTermDebtMember2026-03-310001898718us-gaap:SecuredDebtMember2025-12-310001898718gmrs:SeniorSecuredTermLoansMember2025-12-310001898718gmrs:SeniorSecuredNotesMember2025-12-310001898718gmrs:OtherLongTermDebtMember2025-12-310001898718gmrs:SeniorSecuredTermLoansMember2026-01-012026-03-310001898718us-gaap:CommonClassBMember2025-03-310001898718us-gaap:CommonStockMember2026-03-310001898718us-gaap:CommonStockMember2025-12-310001898718us-gaap:CommonStockMember2025-03-310001898718us-gaap:CommonStockMember2024-12-310001898718us-gaap:CommonClassBMemberus-gaap:SubsequentEventMember2026-05-140001898718us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2026-05-140001898718us-gaap:CommonClassAMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2026-05-140001898718gmrs:VotingWarrants2026Member2026-03-060001898718gmrs:NonVotingWarrants2026Member2026-03-060001898718gmrs:Warrants2024Memberus-gaap:CommonClassAMember2024-05-310001898718gmrs:KohlbergKravisRobertsCo.L.pMemberus-gaap:CommonClassAMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2026-05-120001898718gmrs:HpsMemberus-gaap:CommonClassBMemberus-gaap:SubsequentEventMember2026-05-120001898718gmrs:HpsMemberus-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2026-05-120001898718gmrs:Warrants2024Member2024-05-3100018987182025-03-310001898718gmrs:InvestmentFundsAffiliatedWithKohlbergKravisRobertsCo.L.p.Membergmrs:GmrSolutionsInc.Membergmrs:GmrSolutionsInc.Member2015-04-280001898718us-gaap:USTreasurySecuritiesMemberus-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2026-03-310001898718gmrs:PreferredOrFixedRateCapSecuritiesMemberus-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2026-03-310001898718gmrs:CorporateAndMunicipalBondsMemberus-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2026-03-310001898718us-gaap:USTreasurySecuritiesMember2026-03-310001898718us-gaap:FairValueInputsLevel2Member2026-03-310001898718us-gaap:FairValueInputsLevel1Member2026-03-310001898718us-gaap:USTreasurySecuritiesMemberus-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2025-12-310001898718gmrs:PreferredOrFixedRateCapSecuritiesMemberus-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2025-12-310001898718gmrs:CorporateAndMunicipalBondsMemberus-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2025-12-310001898718us-gaap:USTreasurySecuritiesMember2025-12-310001898718us-gaap:FairValueInputsLevel2Member2025-12-310001898718us-gaap:FairValueInputsLevel1Member2025-12-310001898718gmrs:PreferredOrFixedRateCapSecuritiesMember2026-03-310001898718gmrs:PreferredOrFixedRateCapSecuritiesMember2025-12-310001898718gmrs:CorporateAndMunicipalBondsMember2026-03-310001898718gmrs:CorporateAndMunicipalBondsMember2025-12-310001898718gmrs:RestrictedStockUnitsNonCashSettledPerformanceStockUnitsAndPerformanceBasedStockOptionsMembergmrs:AmendedEquityPlan2015Member2026-01-012026-03-310001898718gmrs:TimeBasedOptionsAndCashSettledPerformanceUnitsMembergmrs:AmendedEquityPlan2015Member2025-01-012025-03-310001898718gmrs:PrivatePlacementWarrantsMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-05-150001898718us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001898718us-gaap:CommonStockMember2025-01-012025-03-310001898718gmrs:AmendedEquityPlan2015Member2026-03-310001898718us-gaap:FairValueInputsLevel3Member2025-12-310001898718us-gaap:PerformanceSharesMembergmrs:AmendedEquityPlan2015Member2026-03-310001898718us-gaap:PerformanceSharesMembergmrs:AmendedEquityPlan2015Member2026-01-012026-03-310001898718gmrs:KohlbergKravisRobertsCo.L.p.Memberus-gaap:RelatedPartyMember2015-04-282015-04-280001898718gmrs:KohlbergKravisRobertsCo.L.p.Memberus-gaap:RelatedPartyMember2026-01-012026-03-310001898718gmrs:KohlbergKravisRobertsCo.L.p.Memberus-gaap:RelatedPartyMember2025-01-012025-03-310001898718us-gaap:SubsequentEventMember2026-05-1400018987182026-03-062026-03-0600018987182025-09-192025-09-1900018987182024-05-012024-05-3100018987182026-03-0600018987182025-01-012025-12-310001898718gmrs:WorkersCompensationInsuranceReserveMember2026-03-310001898718gmrs:GeneralOrProfessionalLiabilityInsuranceReserveMember2026-03-310001898718gmrs:AutomobileInsuranceReserveMember2026-03-310001898718gmrs:WorkersCompensationInsuranceReserveMember2025-12-310001898718gmrs:GeneralOrProfessionalLiabilityInsuranceReserveMember2025-12-310001898718gmrs:AutomobileInsuranceReserveMember2025-12-3100018987182024-12-310001898718us-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2026-03-310001898718us-gaap:AssetPledgedAsCollateralMembergmrs:InsuranceProgramsReservesAndDepositsMember2025-12-310001898718gmrs:TimeBasedOptionsAndCashSettledPerformanceUnitsMembergmrs:AmendedEquityPlan2015Member2026-01-012026-03-310001898718us-gaap:FairValueInputsLevel3Member2026-03-3100018987182024-08-012024-08-3100018987182025-01-012025-03-310001898718us-gaap:CommonClassAMember2026-01-012026-03-310001898718us-gaap:CommonClassBMember2026-03-310001898718gmrs:PrivatePlacementWarrantsMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-05-152026-05-150001898718gmrs:Warrants2024Memberus-gaap:CommonClassAMember2024-05-012024-05-310001898718us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-3100018987182026-03-3100018987182025-12-310001898718us-gaap:CommonClassBMember2026-06-010001898718us-gaap:CommonClassAMember2026-06-0100018987182026-01-012026-03-31xbrli:sharesiso4217:USDxbrli:puregmrs:Votegmrs:itemiso4217:USDxbrli:shares\n\n[Table of Contents](#TOC)\n\n****​\n\n​\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n**FORM ****10-Q**\n\n**(MARK ONE)**\n\n☒\n\n**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the quarterly period ended****March 31, 2026**\n\n☐\n\n**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the transition period from               to              **\n\n**Commission File Number:****001-43289******\n\n**GMR Solutions Inc.**\n\n**(Exact name of registrant as specified in its charter)**\n\n​\n\n​\n\n​\n\n​\n\n**Delaware**\n\n**  ​ ​ ​**\n\n**47-3615769**\n\n**(State or other jurisdiction of********incorporation or organization)**\n\n​\n\n**(I.R.S. Employer********Identification No.)**\n\n**4400 Hwy 121****,****Suite 700********Lewisville****,****TX********(Address of principal executive offices)**\n\n​\n\n**75056********(Zip Code)**\n\n​\n\n**(****972****)****459-4919**\n\n**(Registrant’s telephone number, including area code)**\n\n**Not Applicable**\n\n**(Former name, former address and former fiscal year, if changed since last report)**\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n​\n\n**Title of each class**\n\n**  ​ ​ ​**\n\n**Trading********Symbol(s)**\n\n**  ​ ​ ​**\n\n**Name of each exchange********on which registered**\n\n**Class A common stock, par value $0.0001 per share**\n\n​\n\n**GMRS**\n\n​\n\n**New York Stock Exchange**\n\n​\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☐  No☒\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒  No☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n​\n\n​\n\n​\n\n​\n\n​\n\nLarge accelerated filer\n\n☐\n\nAccelerated filer\n\n☐\n\n​\n\n​\n\n​\n\n​\n\nNon-accelerated filer\n\n☒\n\nSmaller reporting company\n\n☐\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\nEmerging growth company\n\n☐\n\n​\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐  No☒\n\nAs of June 1, 2026, there were 54,011,711 shares of Class A common stock, par value $0.0001 per share, and no shares of Class B common stock, par value $0.0001 per share, of GMR Solutions Inc. issued and outstanding.\n\n​\n\n​\n\n​\n\n​\n\n[Table of Contents](#TOC)\n\nGMR SOLUTIONS INC.\n\nQUARTERLY REPORT ON FORM 10-Q\n\nFOR THE QUARTER ENDED MARCH 31, 2026\n\nTABLE OF CONTENTS\n\n​\n\n​\n\nPage\n\n​\n\n​\n\n[Part I – FINANCIAL INFORMATION](#PartIFINANCIALINFORMATION_844448)\n\n2\n\n​\n\n​\n\n[Item 1. Financial Statements](#Item1)\n\n2\n\n[Condensed Consolidated Balance Sheets](#CONSOLIDATEDBALANCESHEETS_776710)\n\n2\n\n[Condensed Consolidated Statements of Operations](#CONSOLIDATEDSTATEMENTSOFOPERATIONS_40196)\n\n3\n\n[Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity](#STOCKHOLDERSEQUITY_709087)\n\n4\n\n[Condensed Consolidated Statements of Cash Flows](#CASHFLOWS_13999)\n\n5\n\n[Notes to the Unaudited Financial Statements](#NOTESTOTHEUNAUDITEDFINANCIALSTATEMENTS_2)\n\n6\n\n[Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations](#Item2MDA)\n\n21\n\n[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#Item3Quantitative)\n\n36\n\n[Item 4. Controls and Procedures](#Item4Controls)\n\n36\n\n​\n\n​\n\n[Part II – OTHER INFORMATION](#Part2)\n\n37\n\n​\n\n​\n\n[Item 1. Legal Proceedings](#Item1Legal)\n\n37\n\n[Item 1A. Risk Factors](#Item1ARisk)\n\n37\n\n[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#Item2unregistered)\n\n37\n\n[Item 3. Defaults Upon Senior Securities](#Item3Default)\n\n38\n\n[Item 4. Mine Safety Disclosures](#Item4Mine)\n\n38\n\n[Item 5. Other Information](#Item5Other)\n\n38\n\n[Item 6. Exhibits](#Item6Exhibits)\n\n40\n\n​\n\n​\n\n[SIGNATURES](#Signatures)\n\n42\n\n​\n\n​\n\n​\n\ni\n\n[Table of Contents](#TOC)\n\nCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS\n\nThis Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial performance. Forward-looking statements include all statements that are not historical facts. These forward-looking statements may relate to matters which include, but are not limited to, industries, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. In some cases, you can identify these forward-looking statements by the use of words such as “anticipate,” “assume,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “foreseeable,” “future,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would,” the negative version of these words, or similar terms and phrases. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks and uncertainties. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional or local economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. Information concerning these and other factors can be found in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including those set forth in the “Risk Factors” section in our final prospectus (the “IPO Prospectus”) filed with the SEC on May 14, 2026 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, relating to our Registration Statement on Form S-1 (File No. 333-295169) (the “Registration Statement”). Copies are available on the SEC’s website, www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein. In light of the significant uncertainties in forward-looking statements, you should not regard such statements as a representation or warranty that the Company will achieve its objectives and plans in any specified timeframe, or at all, and you should not place undue reliance on any forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.\n\n​\n\nWEBSITE AND SOCIAL MEDIA DISCLOSURE\n\nWe may use our website (www.globalmedicalresponse.com), Facebook page (www.facebook.com/GlobalMedicalResponse), X (Twitter) (www.x.com/GMR_Social), LinkedIn (www.linkedin.com/company/Global-Medical-Response), and Instagram (www.instagram.com/Global_Medical_Response), accounts as channels of distribution of company information. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the “Investor Email Alerts” section of our website at https://investors.globalmedicalresponse.com/resources/investor-email-alerts/default.aspx. The contents of our website, any alerts and social media channels are not, however, a part of this report.\n\n​\n\n​\n\n​\n\n1\n\n[Table of Contents](#TOC)\n\n**Part I - FINANCIAL INFORMATION**\n\n​"}